Medical Footwear Market Report 2026

The medical footwear market size has grown strongly in recent years. It will grow from $11.43 billion in 2025 to $12.48 billion in 2026 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to increasing prevalence of diabetes, rising aging population, growth in orthopedic disorders, higher awareness of foot health, expansion of specialty footwear stores.

The medical footwear market size is expected to see strong growth in the next few years. It will grow to $17.5 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to technological advancements in footwear design, growing demand for customized medical footwear, rising healthcare expenditure, expansion of e-commerce platforms, increasing focus on preventive healthcare. Major trends in the forecast period include rising adoption of diabetic-friendly footwear, growing demand for custom-fit and orthopedic designs, increasing use of lightweight and cushioned materials, expansion of online sales channels for medical footwear, higher focus on preventive foot care solutions.

The rapid rise in the prevalence of foot-related conditions such as bunions and hallux valgus, plantar fasciitis, Achilles tendonitis, and arthritis is significantly driving the growth of the medical footwear market. These conditions generally refer to various issues affecting the feet that cause discomfort and pain. Foot-related problems are particularly common among individuals with diabetes, with conditions like bunions, plantar fasciitis, Achilles tendonitis, and arthritis frequently observed in this population. As a result, healthcare professionals often recommend medical footwear for these patients. For example, in January 2023, Everyday Health, a US-based digital media company, reported that approximately 23% of adults aged 18 to 65 and 36% of those over 65 are affected by bunions. These foot deformities are notably more prevalent in women than in men, potentially due to high heels compressing the toes. Therefore, the increasing incidence of these foot-related issues is propelling the growth of the medical footwear market.

Major companies operating in the medical footwear market are concentrating on enhancing advanced manufacturing capabilities, such as custom footwear production units, to improve patient-specific care, operational efficiency, and clinical outcomes. Custom footwear manufacturing facilities are specialized units that utilize prescription-based design inputs, digital assessment technologies, and customization techniques to produce footwear tailored to individual foot conditions, enabling precise fit optimization, condition-specific support, and scalable personalized production. For instance, in June 2024, FootSecure, an India-based medical footwear manufacturer, in collaboration with the Karnataka Institute of Endocrinology & Research, inaugurated a custom footwear manufacturing facility in Bengaluru with an investment of Rs 30 lakh. The facility produces prescription-driven footwear for patients with foot conditions, offering six different models and advanced customization features. It also incorporates FootSecure’s digital platforms, Wound360 and Foot360, which equip healthcare providers with tools for diagnosis and treatment. This strategic collaboration strengthens FootSecure’s ability to serve patients while enhancing production capabilities and care solutions.

In June 2023, Careismatic Brands, Inc., a US-based medical apparel company, acquired BALA footwear for an undisclosed sum. This acquisition marks a significant milestone in Careismatic's mission to provide exceptional products tailored to the needs of healthcare providers worldwide. The Careismatic team is excited to introduce BALA footwear to its customers and work towards their shared vision of improving the well-being of those committed to caring for others. BALA footwear, based in the US, specializes in dynamic, high-performance shoes designed specifically for healthcare professionals.

Major companies operating in the medical footwear market are New Balance Athletics Inc., Dansko LLC, Sanita Clogs Inc., DJO LLC (Dr. Comfort), Orthofeet Inc., Aetrex Worldwide Inc., Vionic Group LLC, Gravity Defyer Corp, Drew Shoe Corporation, Alegria Shoe Shop LLC, Nurse Mates Inc., Darco International Inc., Dr. Foot Inc., Duna Co Ltd., Extro Style LLC, Klogs Footwear Inc., Novamed s.r.o., SAS Shoes Inc., Watts Footwear Inc., Dr. Zen Inc., Propét USA Inc., Apex Foot Health Industries LLC.

North America was the largest region in the medical footwear market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical footwear market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the medical footwear market report are Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.

The medical footwear market consists of sales of wide-fitting shoes, shoes with extra strong heels, padded tongues, or removable footpads, and shoes for fallen arches. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.